Loading...
Loading...
OMIC| Name | Value |
|---|---|
| Revenues | 0.4M |
| Cost of Revenue | 2.6M |
| Gross Profit | -2.1M |
| Operating Expense | 24.7M |
| Operating I/L | -26.8M |
| Other Income/Expense | 1.8M |
| Interest Income | 2.1M |
| Pretax | -25.0M |
| Income Tax Expense | 1.7M |
| Net Income/Loss | -25.0M |
Singular Genomics Systems, Inc. is a life science technology company specializing in next generation sequencing and multiomics technology. The company's primary revenue streams come from the manufacturing and sale of the G4 Instrument, a benchtop next generation sequencer, along with a range of associated consumable kits. Additionally, the company offers the PX Integrated Solution, which integrates single cell analysis, spatial analysis, genomics, and proteomics into a versatile multiomics solution. Singular Genomics Systems, Inc. has established partnerships with leading companies in the life sciences industry to validate their library preparation kits on the G4, further contributing to their revenue generation.
